About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting

Poster Presentations to Highlight Tissue-Conserving, Machine Learning Tool for Enhanced Sequencing Efficiency and Innovations in Quality Control, Predictive Tools for Precision Oncology and Comparative Molecular Analysis

BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions today announced that four abstracts have been accepted for presentation at the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo, taking place November 19 - 23 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada.

Details of BostonGene’s presence at AMP are below:

Poster presentations:

Morphological Bone Score: Assessment Tool for Predicting Downstream Processing Success for Decalcified Tissue Samples: A Cost-Saving Approach in Precision Oncology

Date & time: Friday, November 22, 2024 | 9:15 AM - 10:15 AM PST

Presenter: Alexander Bagaev, PhD, BostonGene

Decalcification of bone and other diagnostic tissue often leads to loss of nucleic acid integrity and subsequent next-generation sequencing failures. BostonGene developed a morphological bone scoring tool to accurately assess tissue quality and identify samples suitable for downstream sequencing.

Depth ratio distortions in whole exome sequencing (WES) as a quality control metric for copy number alterations calling

Date & time: Friday, November 22, 2024 | 9:15 AM - 10:15 AM PST

Presenter: Hayk Hovhannisyan, PhD, BostonGene

Copy number alterations (CNAs) in genomic DNA may be predictive and prognostic biomarkers for many human cancers. However, accurate CNA detection with whole exome sequencing remains elusive due to depth ratio distortion. BostonGene laboratories developed a depth ratio distortion metric that can consistently enhance the reliability of CNA detection in tumor samples.

Predicting DNA/RNA Extraction Yields for NGS Using Machine Learning-Based Analysis of H&E-Stained Slides

Date & time:
Saturday, November 23, 2024 | 9:15 AM - 10:15 AM PST

Speaker: Alexander Bagaev, PhD, BostonGene

To ensure high-quality DNA/RNA extractions while conserving valuable tissue, BostonGene pioneered and validated a novel machine learning-based tool to predict tumor tissue requirement and yield. By improving the precision of nucleic acid yield predictions, this tool conserves tissue and minimizes the failure rates of clinical next-generation sequencing workflows.

Comparative Molecular Analysis of Clear Cell Sarcoma and Cutaneous Melanomas: Key Genetic Insights for Diagnosis

Date & time: Saturday, November 23, 2024 | 9:15 AM - 10:15 AM PST

Presenter: Hayk Hovhannisyan, PhD, BostonGene

Clear cell sarcoma and cutaneous melanoma share immunohistochemistry diagnostic markers, rendering accurate diagnosis challenging. This study used whole exome and transcriptome sequencing with pathological assessment to reveal new genomic and transcriptomic distinctions, including over 2000 non-overlapping genes, which could be used to improve diagnostic accuracy and treatment selection in future patients.

Please visit the AMP 2024 Annual Meeting & Expo website for more information. Abstracts are also published in the online-only supplement to the Journal of Molecular Diagnostics.

About BostonGene Corporation

BostonGene is a biotechnology company specializing in advanced computational biology and precision medicine. Founded in 2015, BostonGene has consistently pushed the boundaries of innovation to improve patient care and accelerate drug development. Our AI-powered multiomics platform decodes cancer patients' molecular profiles, including their immune system and tumor microenvironment, to uncover key disease drivers, identify novel drug targets and recommend the most effective treatments. With advanced bioanalytics, an indication-specific cancer library and a next-generation CLIA-certified, CAP-accredited high-complexity laboratory, we deliver precise, clinically validated insights that drive precision medicine and advance oncology research. For more information, visit www.BostonGene.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.